Skip to content
BPC-157 5mg

BPC-157 5mg

£20 (Inc. VAT)

BPC-157 is a synthetic pentadecapeptide comprising fifteen amino acids, corresponding to a defined sequence originally identified within a larger gastric-derived protein. It is supplied as a highly purified lyophilised powder for use in laboratory research applications.

Within experimental settings, BPC-157 is investigated as a model oligopeptide for studying peptide-mediated signalling processes. Its well-characterised physicochemical properties support reproducible use across biochemical, cellular, and preclinical research systems.

Category:

Product:  BPC-157

Synonyms / Designations: BPC-157, Body Protection Compound-157, PL-14736 (research designation)
CAS Number: 1628202-19-6
Molecular Formula: C₆₄H₁₀₂N₁₆O₂₄
Molecular Weight: 1479.6 g/mol
Purity: ≥99% (HPLC)
Appearance: White to off-white lyophilised powder
Pack Size: 5 mg (total)
Storage Conditions: Store desiccated, protected from light, at –20°C or below
Solubility: Soluble in water and buffered aqueous solutions

Research Applications

BPC-157 is commonly utilised in research involving:

  • Investigation of short peptide-mediated signalling pathways
  • Analysis of nitric oxide-associated signalling mechanisms
  • Studies of growth factor-related intracellular networks
  • In vitro evaluation of cytoskeletal organisation and cell-matrix interactions
  • Mechanistic studies in preclinical and ex vivo experimental models

Experimental outcomes may vary according to concentration, exposure duration, assay design, and model system.

Technical Specifications

Parameter Specification
Purity (HPLC) ≥99%
Peptide Type Synthetic pentadecapeptide
Molecular Weight 1479.6 g/mol
Appearance White to off-white lyophilised powder
Solubility Water and buffered aqueous solutions
Storage Desiccated, protected from light, at –20°C or below
Pack Size 5 mg

 

Handling and Reconstitution

  • Handle under dry conditions, as the peptide is hygroscopic
  • Reconstitute using sterile water or an appropriate buffered aqueous solution according to experimental requirements
  • Avoid vigorous agitation during dissolution
  • Filter sterilisation (e.g. 0.22 µm) may be performed where required
  • Aliquot reconstituted solutions and store at –20°C or below to minimise degradation
  • Avoid repeated freeze-thaw cycles

Precautions

  • Experimental performance is dependent on concentration, exposure conditions, and model system
  • Appropriate controls should be incorporated into study designs due to the peptide’s reported interactions with multiple signalling pathways
  • Exposure to moisture, elevated temperatures, or prolonged light may reduce stability

As of 2022, BPC-157 (PL-14736) is included on the World Anti-Doping Agency (WADA) Prohibited List under category S0. This classification does not relate to its use as a laboratory research material.

For laboratory research use only. Not for human consumption, therapeutic use, diagnostic procedures, or veterinary applications.

Related products